Avsana Labs

Avsana Labs is a small biotechnology startup based in Dallas, Texas, founded in September 2020. The company is a spin-off from the University of Texas at Dallas (UT Dallas), employing a team of four individuals and generating approximately $0.5 million in revenue. Avsana Labs focuses on developing innovative viral diagnostic testing and environmental viral monitoring solutions. Their groundbreaking approach utilizes a digital nanobubble methodology, aiming to revolutionize the way we detect and track viral infections. The company's technology, developed under an R01 NIAID grant to UT Dallas, is intended to enhance the speed, accuracy, and cost-effectiveness of existing viral testing methods. Avsana Labs collaborates closely with UT Dallas and the University of Texas Southwestern Medical School, accelerating the development and commercialization of its technology. Their ultimate goal is to significantly contribute to public health by mitigating the spread of contagious viral infections and reducing the impact of pandemics. To learn more about Avsana Labs and its groundbreaking technology, visit their website at avsana.com.